Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 - 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025.

“Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscape, and discusses major trends. The report offers the most up-to-date industry data on the actual market situation, and future outlook for global human immunodeficiency virus (HIV) drugs market. The report includes historical data from 2015 to 2018, and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global human immunodeficiency virus (HIV) drugs market. The report explores detailed analysis of top 22 HIV drugs market assessment globally from 2015 to 2018 and forecasts to 2025. The report also details the latest happenings about the global research & development of HIV drugs.

Additionally, the report includes an assessment of clinical trials and promising human immunodeficiency virus (HIV) drugs in clinical development. Key trends in terms of collaboration, partnerships, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global human immunodeficiency virus (HIV) drugs market.

The report concludes with the profiles of major players in the global human immunodeficiency virus (HIV) drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

The Major Companies Dominating this Market for its Drugs, Services and Continuous Drugs Developments are:

• AbbVie
• Merck
• Gilead Sciences
• Bristol–Myers Squibb
• Janssen (Johnson&Johnson)
• GlaxoSmithKline (GSK)

Top 22 Human Immunodeficiency Virus (HIV) Drugs Covered Under this Report are:

• Tivicay
• Triumeq
• Juluca
• Epzicom
• Selzentry
• Kaletra
• Sustiva
• Reyataz
• Atripla
• Truvada
• Viread
• Complera
• Stribild
• Genvoya
• Biktarvy
• Descovy
• Odefsey
• Prezista/Prezcobix
• Edurant
• Isentress
• Pifeltro
• Delstrigo

The Latest Industry Data Included in this Report:

• Global HIV Drugs Market Size & Analysis (2015 – 2025)
• Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 – 2025
• Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 – 2025)
• Promising HIV Drugs in Clinical Development
• HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018
• Major Deals (Key Agreements, Partnerships & Collaborations)
• Latest Happenings in Global HIV Drugs Market
• Key Drivers & Inhibitors of the Global HIV Drugs Market
• Major Companies Analysis

The Answers to the Following Key Questions can be found in the Report:

• What is the size of the global HIV drugs market during 2015 -2025?
• What will be the revenue generated by each drug during the forecast period?
• Which major drug provides the highest market share?
• How are the overall market and major drugs growing?
• What are the key drivers and inhibitors in the current market?
• What will be the impact of drivers and inhibitors in the future?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?

1. Executive Summary
   
   2. Global HIV Drugs Market Size & Analysis (2015 – 2025)
   
   3. Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 – 2025
   
   4. Latest Happenings in Global HIV Drugs Market
   
   5. Key Drivers & Inhibitors of the Global HIV Drugs Market
   5.1 Market Drivers
   5.2 Inhibitors
   
   6. Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 – 2025)
   6.1 Tivicay (dolutegravir)
   6.2 Triumeq (dolutegravir/abacavir/lamivudine)
   6.3 Juluca (dolutegravir and rilpivirine)
   6.4 Epzicom (abacavir and lamivudine)
   6.5 Selzentry (maraviroc)
   6.6 Kaletra (Iopinavir/ritonavir)
   6.7 Sustiva (efavirenz)
   6.8 Reyataz (atazanavir)
   6.9 Atripla (efavirenz/emtricitabine/tenofovir)
   6.10 Truvada (emtricitabine/tenofovir disoproxil fumarate)
   6.11 Viread (tenofovir disoproxil fumarate)
   6.12 Complera (emtricitabine, rilpivirine, and tenofovir disoproxil fumarate)
   6.13 Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
   6.14 Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)
   6.15 Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide)
   6.16 Descovy (emtricitabine and tenofovir alafenamide)
   6.17 Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide)
   6.18 Prezista/Prezcobix (darunavir ethanolate /cobicistat)
   6.19 Edurant (rilpivirine)
   6.20 Isentress (raltegravir)
   6.21 Pifeltro (doravirine)
   6.22 Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate)
   
   7. Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs Market
   
   8. Promising HIV Drugs in Clinical Development
   
   9. HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018
   
   10. Key Companies Analysis
   10.1 AbbVie
   10.1.1 Business Overview
   10.1.2 Recent Development
   10.2 GlaxoSmithKline (GSK)
   10.2.1 Business Overview
   10.2.2 Recent Development
   10.3 Gilead Sciences
   10.3.1 Business Overview
   10.3.2 Recent Development
   10.4 Merck
   10.4.1 Business Overview
   10.4.2 Recent Development
   10.5 Bristol Myers Squibb
   10.5.1 Business Overview
   10.5.2 Recent Development
   10.6 Janssen (Johnson & Johnson)
   10.6.1 Business Overview
   10.6.2 Recent Development

List of Tables

Table 3–1: Global HIV Drugs Market Share & Y–o–Y Growth (%), 2015 – 2018
Table 3–2: Global HIV Drugs Market Share & Y–o–Y Growth Forecast (%), 2019 – 2025
Table 7–1: Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs Market

List of Figures

Figure 2–1: Global HIV Drugs Market Size (Million US$),2015 – 2018
Figure 2–2: Global HIV Drugs Market Size Forecast (Million US$),2019 – 2025
Figure 6–1: Global Tivicay Market Value (Million US$),2015 – 2018
Figure 6–2: Global Tivicay Market Value Forecast (Million US$),2019 – 2025
Figure 6–3: Global Triumeq Market Value (Million US$),2015 – 2018
Figure 6–4: Global Triumeq Market Value Forecast (Million US$),2019 – 2025
Figure 6–5: Global Juluca Market Value (Million US$),2015 – 2018
Figure 6–6: Global Juluca Market Value Forecast (Million US$),2019 – 2025
Figure 6–7: Global Epzicom Market Value (Million US$),2015 – 2018
Figure 6–8: Global Epzicom Market Value Forecast (Million US$),2019 – 2025
Figure 6–9: Global Selzentry Market Value (Million US$),2015 – 2018
Figure 6–10: Global Selzentry Market Value Forecast (Million US$),2019 – 2025
Figure 6–11: Global Kaletra Market Value (Million US$),2015 – 2018
Figure 6–12: Global Kaletra Market Value Forecast (Million US$),2019 – 2025
Figure 6–13: Global Sustiva Market Value (Million US$),2015 – 2018
Figure 6–14: Global Sustiva Market Value Forecast (Million US$),2019 – 2025
Figure 6–15: Global Reyataz Market Value (Million US$),2015 – 2018
Figure 6–16: Global Reyataz Market Value Forecast (Million US$),2019 – 2025
Figure 6–17: Global Atripla Market Value (Million US$),2015 – 2018
Figure 6–18: Global Atripla Market Value Forecast (Million US$),2019 – 2025
Figure 6–19: Global Truvada Market Value (Million US$),2015 – 2018
Figure 6–20: Global Truvada Market Value Forecast (Million US$),2019 – 2025
Figure 6–21: Global Viread Market Value (Million US$),2015 – 2018
Figure 6–22: Global Viread Market Value Forecast (Million US$),2019 – 2025
Figure 6–23: Global Complera Market Value (Million US$),2015 – 2018
Figure 6–24: Global Complera Market Value Forecast (Million US$),2019 – 2025
Figure 6–25: Global Stribild Market Value (Million US$),2015 – 2018
Figure 6–26: Global Stribild Market Value Forecast (Million US$),2019 – 2025
Figure 6–27: Global Genvoya Market Value (Million US$),2015 – 2018
Figure 6–28: Global Genvoya Market Value Forecast (Million US$),2019 – 2025
Figure 6–29: Global Biktarvy Market Value Forecast (Million US$),2018 – 2025
Figure 6–30: Global Descovy Market Value (Million US$),2015 – 2018
Figure 6–31: Global Descovy Market Value Forecast (Million US$),2019 – 2025
Figure 6–32: Global Odefsey Market Value (Million US$),2015 – 2018
Figure 6–33: Global Odefsey Market Value Forecast (Million US$),2019 – 2025
Figure 6–34: Global Prezcobix Market Value (Million US$),2015 – 2018
Figure 6–35: Global Prezcobix Market Value (Million US$),2019 – 2025
Figure 6–36: Global Edurant Market Value (Million US$),2015 – 2018
Figure 6–37: Global Edurant Market Value Forecast (Million US$),2019 – 2025
Figure 6–38: Global Isentress Market Value (Million US$),2015 – 2018
Figure 6–39: Global Isentress Market Value Forecast (Million US$),2019 – 2025
Figure 6–40: Global Pifeltro Market Value & Forecast (Million US$),2018 – 2025
Figure 6–41: Global Delstrigo Market Value & Forecast (Million US$),2018 – 2025